In a study conducted on rats, [290] inhibition of NOX1/4 using GKT137831 significantly reduced portal pressure, improved hyperdynamic circulation, mesenteric angiogenesis, and arterial hyporesponsiveness in rats with portal hypertension. Here, NOX1 is linked to portal hypertension.